[1]
Reich, K., Langley, R.G., Silvestre, J.F., Staumont-Salle, D., Costanzo, A., Pink, A., Paller, A., Katoh, N., Wollenberg, A., Warren, R.B., Øland, C.B., Tindberg, A.-M., Gjerum, L. and Simpson, E. 2024. Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials . SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s375. DOI:https://doi.org/10.25251/skin.8.supp.375.